The AASM Payer Policy Review Committee (PPRC) has received several member inquiries regarding denials for prescribing concomitant medications for the treatment of narcolepsy. Following review of several payers’ pharmaceutical policies and a meeting with a payer representative, it is clear that payers have a [...]

The AASM has sunset its initiative to evaluate coverage policies for diagnostic sleep testing services, and the AASM Payer Policy Review Committee is now shifting its focus to other areas of need, including payer coverage of medications for patients with hypersomnia, payer requirements for [...]

On Feb. 15, 2023, the American Academy of Sleep Medicine released the AASM Manual for the Scoring of Sleep and Associated Events, Version 3. Based on the recommendations of the AASM Scoring Manual Committee, the AASM Board of Directors approved several changes in this [...]

The AASM Sleep Clinical Data Registry (Sleep CDR) has been approved by the Centers for Medicare & Medicaid Services (CMS) for inclusion in the Quality Payment Program (QPP) as a Qualified Clinical Data Registry (QCDR) for 2023. Sleep medicine professionals now can use Sleep [...]

With the COVID-19 pandemic and the Philips PAP device recall both continuing into 2022, it didn’t feel like a “new” year for sleep medicine professionals when Jan. 1 arrived. However, it was a promising sign when 170 sleep clinicians gathered in Phoenix in February [...]

On Dec. 19, the Consolidated Appropriations Act, 2023, was finalized. This legislation provides approximately $1.7 trillion in spending and includes policies that extend beyond appropriations in many different areas. The legislation includes physician reimbursement and telehealth provisions that are especially important for sleep medicine [...]